OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 55 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $200,000 | -1.0% | 40,692 | 0.0% | 0.00% | – |
| Q3 2016 | $202,000 | -2.4% | 40,692 | 0.0% | 0.00% | – |
| Q2 2016 | $207,000 | -4.2% | 40,692 | +7.4% | 0.00% | – |
| Q1 2016 | $216,000 | -45.0% | 37,892 | 0.0% | 0.00% | – |
| Q4 2015 | $393,000 | -45.9% | 37,892 | -3.6% | 0.00% | -100.0% |
| Q3 2015 | $726,000 | -8.3% | 39,292 | -3.4% | 0.00% | 0.0% |
| Q2 2015 | $792,000 | +18.2% | 40,692 | +6.8% | 0.00% | 0.0% |
| Q1 2015 | $670,000 | +27.9% | 38,092 | +16.2% | 0.00% | – |
| Q4 2014 | $524,000 | +26.3% | 32,792 | -0.6% | 0.00% | – |
| Q3 2014 | $415,000 | -18.9% | 32,992 | +0.6% | 0.00% | – |
| Q2 2014 | $512,000 | +19.9% | 32,792 | +0.8% | 0.00% | – |
| Q1 2014 | $427,000 | -21.9% | 32,521 | -4.4% | 0.00% | – |
| Q4 2013 | $547,000 | -28.4% | 34,005 | -26.0% | 0.00% | -100.0% |
| Q3 2013 | $764,000 | +44.4% | 45,923 | -12.7% | 0.00% | 0.0% |
| Q2 2013 | $529,000 | – | 52,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|